Life Saving Drugs Program resources – Pompe disease

A collection of resources for health professionals to help people with Pompe disease access alglucosidase alfa (Myozyme®) and avalglucosidase alfa (Nexviazyme®) under the Life Saving Drugs Program.

Collection description

This collection contains guidelines, forms and documents related to accessing alglucosidase alfa (Myozyme®) and avalglucosidase alfa (Nexviazyme®) under the Life Saving Drugs Program for patients with:

  • infantile-onset Pompe disease
  • late-onset Pompe disease.

Click to view the product information for Myozyme® and Nexviazyme® on the Therapeutic Goods Administration website.



Medicines review documents

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Health sector

Help us improve

If you would like a response please use the enquiries form instead.